Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian P Vivian

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 12, 2018
Production of Recombinant Killer Immunoglobulin-Like Receptors for Crystallography and Luminex-Based AssaysPhillip Pymm, Julian P Vivian
Biochemical and Biophysical Research Communications|July 1, 2025
Structural insights into monoterpene cyclisation of limonene synthase from Cannabis sativaDanielle Wiles, James Roest, Julian P Vivian, et al.
Current Opinion in Immunology|November 13, 2012
Human leukocyte antigen-associated drug hypersensitivityPatricia T Illing, Julian P Vivian, Anthony W Purcell, et al.
The FEBS Journal|December 30, 2023
Structure of the murine CD94-NKG2A receptor in complex with Qa-1<sup>b</sup> presenting an MHC-I leader peptideBruce J MacLachlan, Lucy C Sullivan, Andrew G Brooks, et al.
Biochemical Society Transactions|December 1, 2020
A pocket guide on how to structure SARS-CoV-2 drugs and therapiesDene R Littler, Bruce J MacLachlan, Gabrielle M Watson, et al.
Journal of Leukocyte Biology|January 15, 2021
Structural integrity with functional plasticity: what type I IFN receptor polymorphisms revealNicole A de Weerd, Julian P Vivian, San S Lim, et al.
The Journal of Biological Chemistry|July 3, 2025
Prediction of KIR3DL1 and human leukocyte antigen bindingMartin Maiers, Yoram Louzoun, Philip Pymm, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Prediction of KIR3DL1/Human Leukocyte Antigen bindingMartin Maiers, Yoram Louzoun, Philip Pymm, et al.
Biochemical and Biophysical Research Communications|July 2, 2026
A transferrin receptor-based vector enables robust Type-II membrane protein display on mammalian cellsAlexander J Sedgwick, James Roest, Geoff Zhang, et al.
Immunological Reviews|August 19, 2015
A bird's eye view of NK cell receptor interactions with their MHC class I ligandsPhilippa M Saunders, Julian P Vivian, Geraldine M O'Connor, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|January 12, 2018
Production of Recombinant Killer Immunoglobulin-Like Receptors for Crystallography and Luminex-Based AssaysPhillip Pymm, Julian P Vivian
Biochemical and Biophysical Research Communications|July 1, 2025
Structural insights into monoterpene cyclisation of limonene synthase from Cannabis sativaDanielle Wiles, James Roest, Julian P Vivian, et al.
Current Opinion in Immunology|November 13, 2012
Human leukocyte antigen-associated drug hypersensitivityPatricia T Illing, Julian P Vivian, Anthony W Purcell, et al.
The FEBS Journal|December 30, 2023
Structure of the murine CD94-NKG2A receptor in complex with Qa-1<sup>b</sup> presenting an MHC-I leader peptideBruce J MacLachlan, Lucy C Sullivan, Andrew G Brooks, et al.
Biochemical Society Transactions|December 1, 2020
A pocket guide on how to structure SARS-CoV-2 drugs and therapiesDene R Littler, Bruce J MacLachlan, Gabrielle M Watson, et al.
Journal of Leukocyte Biology|January 15, 2021
Structural integrity with functional plasticity: what type I IFN receptor polymorphisms revealNicole A de Weerd, Julian P Vivian, San S Lim, et al.
The Journal of Biological Chemistry|July 3, 2025
Prediction of KIR3DL1 and human leukocyte antigen bindingMartin Maiers, Yoram Louzoun, Philip Pymm, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Prediction of KIR3DL1/Human Leukocyte Antigen bindingMartin Maiers, Yoram Louzoun, Philip Pymm, et al.
Biochemical and Biophysical Research Communications|July 2, 2026
A transferrin receptor-based vector enables robust Type-II membrane protein display on mammalian cellsAlexander J Sedgwick, James Roest, Geoff Zhang, et al.
Immunological Reviews|August 19, 2015
A bird's eye view of NK cell receptor interactions with their MHC class I ligandsPhilippa M Saunders, Julian P Vivian, Geraldine M O'Connor, et al.
Pageof 6